Abstract

The editorial office at The Journal of Pediatrics received the first manuscript regarding severe acute respiratory syndrome novel coronavirus 2 (SARS-CoV-2) on February 13, 2020. Through November 30, 2020, nearly 550 manuscripts were submitted regarding SARS-CoV-2 in children and adolescents (Figure). We pause to consider the phases of the pandemic as reflected in manuscript submissions and take stock of the benefits, costs, and concerns of journal editors committed to the peer review process as well as to the rapid dissemination of new information.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call